Gemcitabine metabolic pathway genetic polymorphisms and response in non-small cell lung cancer patients

BACKGROUND AND OBJECTIVE: Gemcitabine is widely used to treat non-small cell lung cancer (NSCLC). To assess the pharmacogenomic effects of the entire gemcitabine metabolic pathway, we genotyped SNPs within the 17 pathway genes using DNA samples from NSCLC patients treated with gemcitabine to determi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Li, Liang, Schaid, Daniel J., Fridley, Brooke L., Kalari, Krishna R., Jenkins, Gregory D., Abo, Ryan P., Batzler, Anthony, Moon, Irene, Pelleymounter, Linda, Eckloff, Bruce W., Wieben, Eric D., Sun, Zhifu, Yang, Ping, Wang, Liewei
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3259218/
https://ncbi.nlm.nih.gov/pubmed/22173087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0b013e32834dd7e2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares